It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Explore the main factors that move a stock index, including macroeconomic data, earnings, and policy changes that influence index levels.
21,956 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
More than 60 analysts now rate the stock Buy as investors await the upcoming earnings release and assess cloud, adver...
AI disruption is rattling markets, but Bitcoin still has unique safeguards. This guide explains why bitcoin safe from...
USOI, a Credit Suisse X-Links Crude Oil ETN, pays sizable monthly distributions but sits in the risky space of unsecu...
A broad sell-off hit four key quantum names after a sharp Monday rally, with profit-taking and sentiment shifts weigh...
A potential federal shift on cannabis could redefine the playing field for Canopy Growth, Tilray, and Green Thumb. Th...
Bitcoin climbs above $71,000, fueling a premarket lift in crypto-linked stocks. Coinbase and Circle lead gains as inv...
When geopolitics collide with global manufacturing, one top EV maker shows how to turn risk into growth. This story d...
A fresh investing approach blends emerging-market debt with high-quality short bonds to deliver higher income and ste...
With the Fed chair signaling a hawkish tilt, markets brace for higher-for-longer policy. History suggests the last ti...
Whale buyers snapped up hundreds of millions of DOGE as SpaceX filed for a Nasdaq debut. The surge boosts bets that d...
Investors face a shifting news landscape as social media becomes the default source for market signals, even as many ...